Abstract
Highly discriminatory markers for celiac disease are needed to identify children with early mucosal lesions and for rapid follow-up. The aim of this study was to evaluate the potential of circulating anti-tissue transglutaminase (tTG) IgA and IgG antibodies in the diagnosis and follow-up of childhood celiac disease. An ELISA using recombinant human tTG was used to measure the levels of IgA and IgG anti-tTG antibodies in 226 serum samples from 57 children with biopsy-verified celiac disease, 29 disease control subjects, and 24 healthy control subjects. All samples were also analyzed for anti-endomysium antibodies (EMA). The levels of IgA and IgG anti-tTG antibodies correlated with the condition of the small intestinal villous structure and the serum levels of IgA EMA. All of the 25 serum samples obtained from untreated patients contained IgA anti-tTG antibodies, and 24 of 25 also had IgA EMA. Of the serum samples from 53 control children, two had IgA anti-tTG antibodies and two had IgA EMA. Children younger than 5 y of age with untreated celiac disease had the highest serum levels of both IgA and IgG anti-tTG. There was already an increase in IgA anti-tTG antibodies after 2 wk of gluten challenge (p < 0.01). Although the criteria-based diagnosis of childhood celiac disease still depends on histologic evaluation of intestinal biopsies, detection of anti-tTG antibodies provides useful complementary diagnostic information. The human recombinant tTG-based ELISA can be used as a sensitive and specific test to support the diagnosis and may also be used in the follow-up of treatment in childhood celiac disease.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- AGA:
-
anti-gliadin antibodies
- AU:
-
arbitrary unit
- EMA:
-
anti-endomysium antibodies
- GC:
-
gluten challenge
- IEL:
-
intraepithelial lymphocytes
- tTG:
-
tissue transglutaminase
References
Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK 1990 Revised criteria for diagnosis of coeliac disease. Arch Dis Child 65: 909–911
Fasano A, Catassi C 2001 Current approaches to diagnosis treatment of celiac disease: an evolving spectrum. Gastroenterology 120: 636–651
Scott H, Kett K, Halstensen T, Hvatum M, Rognum TO, Brandtzaeg P 1992 The humoral immune system in coeliac disease. In: Marsh MN (ed) Coeliac Disease. Blackwell, Oxford, pp 239–282
Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D 1997 Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3: 797–801
Bruce SE, Bjarnason I, Peters TJ 1985 Human jejunal transglutaminase: demonstration of activity, enzyme kinetics substrate specificity with special relation to gliadin coeliac disease. Clin Sci 68: 573–579
Upchurch HF, Conway E, Patterson MKJ, Maxwell MD 1991 Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme. J Cell Physiol 1249: 375–382
Aeschlimann D, Paulsson M 1994 Transglutaminases: protein cross-linking enzymes in tissue body fluids. Thromb Haemost 71: 402–415
D'Argenio G, Cosenza V, Sorrentini I, De Ritis F, Gatto A, Delle Cave M, D'Armiento FP, Mazzacca G 1994 Butyrate, mesalamine factor XIII in experimental colitis in the rat: effects on transglutaminase activity. Gastroenterology 106: 399–404
Szabolcs M, Sipka S, Csorba S 1987 In vitro cross-linking of gluten into high-molecular-weight polymers with transglutaminase. Acta Paediatr Hung 28: 215–227
Larre C, Chiarello M, Blanloeil Y, Chenu M, Gueguen J 1993 Gliadin modifications catalyzed by guinea pig liver transglutaminase. J Food Biochem 17: 267–282
Molberg Ø, Mcadam SN, Körner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Norén O, Roepstorff P, Lundin KEA, Sjöström H, Sollid LM 1998 Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gluten-derived T cells in celiac disease. Nat Med 4: 713–717
van de Wal Y, Kooy Y, van Veelen P, Pena S, Mearin L, Papadopoulos G, Koning F 1998 Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 161: 1585–1588
Dieterich W, Laag E, Schöpper H, Volta U, Ferguson A, Gillet H, Riecken EO, Schuppan D 1998 Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 115: 1317–1321
Sulkanen S, Halttunen T, Laurila K, Kolho K-H, Korponay-Szabó I, Samesto A, Savilahti E, Collin P, Mäki M 1998 Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115: 1322–1328
Malberg K, Malfertheiner P, Bannert N, Günther T 1999 IgA-tissue transglutaminase (tTG)-antibodies are highly sensitive serum markers for celiac disease. Am J Gastroenterol 94: 3079–3080
Vitoria JC, Arrieta A, Arranz C, Ayesta A, Sojo A, Maruri N, García-Masdevall MD 1999 Antibodies to gliadin, endomysium tissue transglutaminase for the diagnosis of celiac disease. J Pediatr Gastroenterol Nutr 29: 571–574
Biagi F, Ellis JH, Yiannakou JY, Brusco G, Swift GL, Smith PM, Corazza GR, Ciclitira PJ 1999 Tissue transglutaminase antibodies in celiac disease. Am J Gastroenterol 94: 2187–2192
Sárdy M, Odenthal U, Kárpáti S, Paulsson M, Smyth N 1999 Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy. Clin Chem 45: 2142–2149
Troncone R, Maurano F, Rossi M, Micillo M, Greco L, Auricchio R, Salerno G, Salvatore F, Sacchetti L 1999 IgA antibodies to tissue transglutaminase: an effective diagnostic test for celiac disease. J Pediatr 134: 166–171
Hansson T, Dahlbom I, Hall J, Holtz A, Elfman L, Dannæus A, Klareskog L 2000 Antibody reactivity against human guinea pig tissue transglutaminase in children with celiac disease. J Pediatr Gastroenterol Nutr 30: 379–384
Bazzigaluppi E, Lampasona V, Barera G, Venerando A, Bianchi C, Chiumello G, Bonifacio E, Bosi E 1999 Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease. J Autoimmun 12: 51–56
Sblattero D, Berti I, Trevisiol C, Marzari R, Tommasini A, Bradbury A, Fasano A, Ventura A, Not T 2000 Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol 95: 1253–1257
Meeuwisse GW 1970 Diagnostic criteria in coeliac disease. Acta Paediatr Scand 59: 461–463
Andersson A-S, Holtz A, Backhans B, Axiö-Fredriksson U-B, Mauch L, Scheckermann C, Dahlbom I 2000 Inhibition of endomysial staining with human tissue transglutaminase. J Pediatr Gastroenterol Nutr 31: S16
Centor RM 1991 Signal detectability: the use of ROC curves their analyses. Med Decis Making 11: 102–106
Grodzinsky E, Jansson G, Skogh T, Stenhammar L, Fälth-Magnusson K 1995 Anti-endomysium anti-gliadin antibodies as serological markers for coeliac disease in childhood: a clinical study to develop a practical routine. Acta Paediatr 84: 294–298
Hansson T, Dannæus A, Kraaz W, Sjöberg O, Klareskog L 1997 Production of antibodies to gliadin by peripheral blood lymphocytes in children with celiac disease: the use of an enzyme-linked immunospot technique for the screening follow-up. Pediatr Res 41: 554–559
Phillips AD 1989 The small intestinal mucosa. In: Whitehead R (ed) Gastrointestinal and Esophageal Pathology. Churchill-Livingstone, Edinburgh, pp 29–39
Spencer JO, MacDonald TT, Diss TC, Walker-Smith JA, Ciclitira PJ, Isaacson PG 1989 Changes in intraepithelial lymphocyte subpopulations in coeliac disease enteropathy associated T cell lymphoma (malignant histiocytosis of the intestine). Gut 30: 339–346
Arranz E, Ferguson A 1993 Intestinal antibody pattern of celiac disease: occurrence in patients with normal jejunal biopsy histology. Gastroenterology 104: 1263–1272
Michaëlsson G, Kraaz W, Gerdén B, Hagforsen E, Hjelmqvist G, Lööf L, Sjöberg O, Scheynius A 1995 Increased lymphocyte infiltration in duodenal mucosa from patients with psoriasis serum IgA antibodies to gliadin. Br J Dermatol 133: 896–904
Seissler J, Boms S, Wohlrab U, Morgenthaler NG, Mothes T, Boehm BO, Scherbaum WA 1999 Antibodies to human recombinant tissue transglutaminase measured by radioligand assay: evidence for high diagnostic sensitivity for celiac disease. Horm Metab Res 31: 375–379
Cataldo F, Lio D, Marino V, Picareli A, Ventura A, Corazza GR 2000 IgG1 antiendomysium IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Gut 47: 366–369
Korponay-Szabó IR, Kovács JB, Lörincz M, Gorácz G, Szabados K, Balogh M 1997 Prospective significance of antiendomysium antibody positivity in subsequently verified celiac disease. J Pediatr Gastroenterol Nutr 25: 56–63
Brusco G, Izzi L, Corazza GR 1998 Tissue transglutaminase antibodies for coeliac disease screening. Ital J Gastroenterol Hepatol 30: 496–497
Miller A, Paspaliaris W, Elliott PR, d'Apice A 1999 Anti-transglutaminase antibodies coeliac disease. Aust N Z J Med 29: 239–242
Acknowledgements
The authors thank Sonja Gertz for invaluable help in recruiting the children involved in this study and Dr. R.A. Harris for linguistic advice.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the Swedish Association against Asthma and Allergy, Agnes and Mac Rudbergs Foundation, Vårdalstiftelsen and the Swedish Medical Research Council.
Rights and permissions
About this article
Cite this article
Hansson, T., Dahlbom, I., Rogberg, S. et al. Recombinant Human Tissue Transglutaminase for Diagnosis and Follow-Up of Childhood Coeliac Disease. Pediatr Res 51, 700–705 (2002). https://doi.org/10.1203/00006450-200206000-00007
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-200206000-00007
This article is cited by
-
Research letters
Indian Pediatrics (2013)
-
Celiac disease diagnosis and gluten-free food analytical control
Analytical and Bioanalytical Chemistry (2010)
